Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Dowling

Showing results (301-310 of 310) with videos related to

Pageof 31
Sort By:
You have reached the last page of results.This site can display upto 310 results.
Science Advances|February 1, 2021
Multiple screening approaches reveal HDAC6 as a novel regulator of glycolytic metabolism in triple-negative breast cancerCatríona M Dowling, Kate E R Hollinshead, Alessandra Di Grande, et al.
Cancer Discovery|November 21, 2019
<i>In Vivo</i> Epigenetic CRISPR Screen Identifies <i>Asf1a</i> as an Immunotherapeutic Target in <i>Kras</i>-Mutant Lung AdenocarcinomaFei Li, Qingyuan Huang, Troy A Luster, et al.
Cancer Research|July 11, 2020
Epigenetic CRISPR Screens Identify <i>Npm1</i> as a Therapeutic Vulnerability in Non-Small Cell Lung CancerFei Li, Wai-Lung Ng, Troy A Luster, et al.
Biorxiv : the Preprint Server for Biology|May 3, 2023
<i>In vivo</i> metabolomics identifies CD38 as an emergent vulnerability in <i>LKB1</i> -mutant lung cancerJiehui Deng, David H Peng, David Fenyo, et al.
American Journal of Hematology|July 22, 2014
Silent cerebral infarction, income, and grade retention among students with sickle cell anemiaAllison A King, Mark J Rodeghier, Julie Ann Panepinto, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 23, 2023
Histone Deacetylase 6 Inhibition Exploits Selective Metabolic Vulnerabilities in LKB1 Mutant, KRAS Driven NSCLCHua Zhang, Christopher S Nabel, Dezhi Li, et al.
Cancer Immunology Research|August 31, 2021
Targeting the Atf7ip-Setdb1 Complex Augments Antitumor Immunity by Boosting Tumor ImmunogenicityHai Hu, Alireza Khodadadi-Jamayran, Igor Dolgalev, et al.
Neurocritical Care|July 20, 2023
Pediatric Moyamoya Revascularization Perioperative Care: A Modified Delphi StudyLisa R Sun, Lori C Jordan, Edward R Smith, et al.
European Journal of Cancer (Oxford, England : 1990)|June 27, 2025
Clinical benefit and cost of plasma-first next-generation sequencing in patients with newly diagnosed advanced non-small cell lung cancer in Ireland: The PLAN studyDavid O'Reilly, Anthony O'Grady, Conor Hayes, et al.
Cancer Cell|December 30, 2019
CDK7 Inhibition Potentiates Genome Instability Triggering Anti-tumor Immunity in Small Cell Lung CancerHua Zhang, Camilla L Christensen, Ruben Dries, et al.
Pageof 31

Showing results (301-310 of 310) with videos related to

Sort By:
Pageof 31
You have reached the last page of results.This site can display upto 310 results.
Science Advances|February 1, 2021
Multiple screening approaches reveal HDAC6 as a novel regulator of glycolytic metabolism in triple-negative breast cancerCatríona M Dowling, Kate E R Hollinshead, Alessandra Di Grande, et al.
Cancer Discovery|November 21, 2019
<i>In Vivo</i> Epigenetic CRISPR Screen Identifies <i>Asf1a</i> as an Immunotherapeutic Target in <i>Kras</i>-Mutant Lung AdenocarcinomaFei Li, Qingyuan Huang, Troy A Luster, et al.
Cancer Research|July 11, 2020
Epigenetic CRISPR Screens Identify <i>Npm1</i> as a Therapeutic Vulnerability in Non-Small Cell Lung CancerFei Li, Wai-Lung Ng, Troy A Luster, et al.
Biorxiv : the Preprint Server for Biology|May 3, 2023
<i>In vivo</i> metabolomics identifies CD38 as an emergent vulnerability in <i>LKB1</i> -mutant lung cancerJiehui Deng, David H Peng, David Fenyo, et al.
American Journal of Hematology|July 22, 2014
Silent cerebral infarction, income, and grade retention among students with sickle cell anemiaAllison A King, Mark J Rodeghier, Julie Ann Panepinto, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 23, 2023
Histone Deacetylase 6 Inhibition Exploits Selective Metabolic Vulnerabilities in LKB1 Mutant, KRAS Driven NSCLCHua Zhang, Christopher S Nabel, Dezhi Li, et al.
Cancer Immunology Research|August 31, 2021
Targeting the Atf7ip-Setdb1 Complex Augments Antitumor Immunity by Boosting Tumor ImmunogenicityHai Hu, Alireza Khodadadi-Jamayran, Igor Dolgalev, et al.
Neurocritical Care|July 20, 2023
Pediatric Moyamoya Revascularization Perioperative Care: A Modified Delphi StudyLisa R Sun, Lori C Jordan, Edward R Smith, et al.
European Journal of Cancer (Oxford, England : 1990)|June 27, 2025
Clinical benefit and cost of plasma-first next-generation sequencing in patients with newly diagnosed advanced non-small cell lung cancer in Ireland: The PLAN studyDavid O'Reilly, Anthony O'Grady, Conor Hayes, et al.
Cancer Cell|December 30, 2019
CDK7 Inhibition Potentiates Genome Instability Triggering Anti-tumor Immunity in Small Cell Lung CancerHua Zhang, Camilla L Christensen, Ruben Dries, et al.
Pageof 31